People · Operator
Named in public records as an officer, director or promoter · active 2010–2025 · Biotechnology, Pharmaceuticals, Other, Mining & Resources
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Novus Therapeutics, Inc. | — | Biotechnology | Series D+ | $226.8M | $575.7M | 2019 |
| Intezyne Technologies, Inc. | — | Pharmaceuticals | Series A | $9.3M | $14.9M | 2013 |
| Blackbird Academy, LLC | — | Other | Seed | $3.0M | $30.3M | 2013 |
| Ohio River Trading Co | — | Other | Seed | $2.8M | $18.6M | 2010 |
| Northfield Capital Corp | — | Other | Seed | $2.4M | $5.8M | 2025 |
| Nighthawk Gold Corp. | — | Mining & Resources | Series A | $300K | $956K | 2023 |
| North American Limestone Corp | — | Other | Pre-Seed | $200K | $4.6M | 2010 |
John McBride at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John McBride on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Wiley | 2 | 5 |
| Stephen McLean | 2 | 4 |
| Morris Prychidny | 2 | 3 |
| Dustin Angelo | 2 | 3 |
| Tom Hingst | 2 | 2 |
| Dana Boyd | 2 | 2 |
| Greg Gould | 2 | 2 |
| Campbell Murray | 1 | 9 |
| Timothy J. Barberich | 1 | 7 |
| Erez Chimovits | 1 | 7 |
| James Robinson | 1 | 6 |
| Bryan Smith | 1 | 6 |
| Eric Klein | 1 | 5 |
| Seth L. Harrison | 1 | 4 |
| Campbell A. Murray | 1 | 4 |
| Keith A. Katkin | 1 | 3 |
| Eric Tremblay | 1 | 3 |
| June Lee | 1 | 3 |
| Cheryl Cohen | 1 | 3 |
| Reinhard J. Ambros | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.